Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levotens Patch and Oxygen-Ozone Therapy for Neck Pain
NCT06099171Phase 3Not yet recruiting
- Sponsor
- Humanitas Research Hospital
- Start
- Feb 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cannabidiol + beta-caryophyllene in Cervicalgia (2 arms), sponsored by Humanitas Research Hospital. Primary endpoint: Neck Disability Index at 14 days. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
cannabidiol + beta-caryophyllene
03
Conditions
Cervicalgia
Beyond the preview
Go deeper on NCT06099171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06099171.